Related Experiment Video

Updated: Aug 30, 2026

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
10:59

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage

Published on: August 21, 2021

Mismatch repair and response to DNA-damaging antitumour therapies

M Bignami1, I Casorelli, P Karran

  • 1Laboratorio di Tossicologia Comparata, Istituto Superiore di Sanita', Viale Regina Elena 299, 00161 Rome, Italy. bignami@iss.it

European Journal of Cancer (Oxford, England : 1990)
|October 3, 2003
PubMed

Insights

DNA mismatch repair (MMR) deficiency can paradoxically increase drug resistance in cancer. Understanding this complex relationship is crucial for improving cancer therapy outcomes and preventing treatment-related cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Antitumour therapies often target cancer cell DNA, making DNA damage responses critical for treatment efficacy.
  • DNA repair mechanisms, while protective, can confer intrinsic drug resistance by removing therapeutic lesions.
  • Previous research suggests a complex, paradoxical link between DNA mismatch repair (MMR) and drug sensitivity.

Purpose of the Study:

  • To review the impact of MMR deficiency on drug resistance in cancer.
  • To evaluate the prognostic value of MMR loss in cancer therapies.
  • To explore the implications of the MMR-drug resistance relationship in the development of secondary malignancies.

Main Methods:

  • Literature review of studies investigating DNA mismatch repair (MMR) and its role in cancer therapy.
  • Analysis of existing data on MMR deficiency, drug sensitivity, and patient outcomes.
  • Synthesis of findings regarding the association between MMR status and treatment-related malignancies.

Main Results:

  • MMR deficiency can lead to increased resistance to certain antitumour drugs.
  • Loss of MMR function may serve as a prognostic factor in specific cancer treatments.
  • An inverse relationship exists between MMR activity and drug resistance, potentially influencing secondary cancer development.

Conclusions:

  • The interplay between DNA mismatch repair (MMR) and drug sensitivity is complex and warrants further investigation.
  • MMR status is an important consideration for predicting therapeutic response and understanding resistance mechanisms.
  • Understanding the MMR-drug resistance axis may aid in mitigating the risk of treatment-induced cancers.

More Related Videos

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells11:06

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

Related Concept Videos

Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair01:48

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.The Mutator Protein Family Plays a Key Role in DNA Mismatch RepairThe human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair01:48

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.The Mutator Protein Family Plays a Key Role in DNA Mismatch RepairThe human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair01:46

Nucleotide Excision Repair

Exposure to mutagens can damage DNA and result in bulky lesions that distort the double-helix structure or impede proper transcription. Damaged DNA can be detected and repaired in a process called nucleotide excision repair (NER). NER employs a set of specialized proteins that first scan DNA to detect a damaged region. Next, NER proteins separate the strands and excise the damaged area. Finally, they coordinate the replacement with new, matching nucleotides.DNA distortion and damageCells are...
Nucleotide Excision Repair01:46

Nucleotide Excision Repair

Exposure to mutagens can damage DNA and result in bulky lesions that distort the double-helix structure or impede proper transcription. Damaged DNA can be detected and repaired in a process called nucleotide excision repair (NER). NER employs a set of specialized proteins that first scan DNA to detect a damaged region. Next, NER proteins separate the strands and excise the damaged area. Finally, they coordinate the replacement with new, matching nucleotides.DNA distortion and damageCells are...